Authors
Latest:
Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment SelectionRanee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.
Latest:
Advanced Practice Providers Are Uniquely Suited for Survivorship CareAdvanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.
Latest:
Unmet Needs and Future Directions in the Management of CIMMartin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.
Latest:
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCCNivolumab/Cabozantinib continued to outperform sunitinib in an updated analysis of the phase 3 CheckMate 9ER trial.
Latest:
Aaron Gerds on JAK Inhibitor Therapy for Anemic Patients With MyelofibrosisAaron T. Gerds, MD, MS, unpacks data seen with momelotinib for patients with anemic myelofibrosis.
Latest:
Discrepancies Exist Between Actual Care and Trial-Based Recommendations in MCLDiscrepancies exist between actual patterns of care and recommendations based on clinical trials in adult patients with mantle cell lymphoma.
Latest:
Addition of Abemaciclib to Aromatase Inhibitor Therapy Prolongs Survival in HR+/HER2- Breast CancerFor patients receiving an aromatase inhibitor for hormone receptor–positive, HER2-negative breast cancer, the addition of abemaciclib doubled median progression-free survival vs placebo.
Latest:
Durvalumab Outcomes Could Change Treatment Approaches in CholangiocarcinomaAdding the immunotherapy to chemotherapy in the frontline setting may improve overall survival for patients with advanced biliary tract cancer.
Latest:
Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital SettingSeth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.
Latest:
Opinion: Now Is the Time to Optimize Electronic Health Record SystemsBuying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.
Latest:
Kristin Daly on the Difference Between Somatic and Germline Variants in Precision OncologyKristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.
Latest:
Cleveland Clinic Opens New Cancer Center in Abu DhabiThe state-of-the-art facility represents the organization’s vision of global cancer care
Latest:
COVID-19 and the Rise of Texting in Health CareThe last thing patients want is to be put on hold or interrupted by calls at work.
Latest:
How Social Media Helps AYA Patients With Cancer Find SupportThe rise of social media platforms has helped foster a community for adolescent and young adult patients with cancer.
Latest:
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast CancerKara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Latest:
Capivasertib/Fulvestrant Boosts Progression-Free Survival in HR+/HER2– Breast CancerCapivasertib plus fulvestrant improved progression-free survival in patients who have hormone-receptor–positive/HER2-negative advanced breast cancer.
Latest:
Improved PFS Outcomes With Elacestrant Correlate With CDK4/6 Duration in ER+/HER2– Metastatic Breast CancerLonger duration of CDK4/6 inhibitor prior to treatment with elacestrant correlated with progression-free survival (PFS) improvements in patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer vs standard-of-care options.
Latest:
Newly Approved Tebentafusp Requires Up-Front Active Toxicity Management in MelanomaTebentafusp, the first FDA-approved treatment option for patients with unresectable or metastatic uveal melanoma, may cause mild cytokine release syndrome, an expert explains.
Latest:
Eric Zack on Disseminated Intravascular Coagulation Prevention and ManagementEric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.
Latest:
Hospice Professionals Use Mind, Body, and Movement Meditation to Reduce StressA program evaluated at Michigan State University has shown that meditation helps combat burnout and promote well-being among health care workers, particularly in hospice settings.
Latest:
Challenges and Impacts Faced by Undocumented Cancer Patients in the Health Care SystemUndocumented patients with cancer face additional barriers to care.
Latest:
La-Urshalar Brock on Testing for HER2 in Patients with Metastatic Breast CancerLa-Urshalar Brock, MSN, FNP-BC, CNM, discusses HER2 status and its implications for patients with breast cancer.
Latest:
Health Care Professionals Can Fight Burnout Through Their Diet“This is a holistic, functional and integrative approach to your mental well-being. So, you start small, and you build up on that. It is not an overnight fix; it is a slow and steady progress.”
Latest:
Nursing Education Can Be a Lifelong Marathon. Are You Ready for the Race?Nursing education should be viewed as a long-course endeavor rather than a sprint.
Latest:
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical CannabisAlyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Latest:
Bring A Nuanced Approach to Venous Thromboembolism ManagementUnderstanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Latest:
Kellie Zeichner Speaks to the Power of Standardized Monitoring Procedures for Patients With Rare TumorsKellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.
Latest:
Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.
Latest:
Oncology Nurse Shares Inspiring Story of HopeLaurel Sopher was diagnosed with breast cancer while pregnant at 15 weeks. Laurel's son, Alexander, was born in 2000. Laurel also delivered twin boys in 2004.
Latest:
Connecting All the Pieces: Helping Patients Make Sense of Their ChemotherapyChemotherapy education is a puzzle personalized for each patient. Each piece of the puzzle represents a different method of instruction to supplement nurses’ interpersonal teaching.
